Kura Oncology News - KURA

Best deals to access real time data!
Trade Alert US
Monthly Subscription
for only
US$67.09
DDE w/Realtime USA (Monthly)
Monthly Subscription
for only
US$34.10
USA Big Cap Pro
Monthly Subscription
for only
US$52.04
VAT not included
Stock Name Stock Symbol Market Stock Type
Kura Oncology Inc KURA NASDAQ Common Stock
  Price Change Price Change % Stock Price High Price Low Price Open Price Close Price Last Trade
  -0.20 -1.54% 12.76 13.08 12.70 13.08 12.96 18:59:37
more quote information »

Recent News

Date Time Source Heading
07:02EDGARCurrent Report Filing (8-k)
15:06EDGARCurrent Report Filing (8-k)
06:30GLOBEKura Oncology to Present at J.P. Morgan Healthcare..
15:11EDGARStatement of Changes in Beneficial Ownership (4)
15:09EDGARInitial Statement of Beneficial Ownership (3)
06:30GLOBEKura Oncology Appoints Kirsten Flowers as Chief Commercial..
09:40EDGARAmended Statement of Ownership (sc 13g/a)
06:37EDGARCurrent Report Filing (8-k)
06:30GLOBEKura Oncology Receives Fast Track Designation for Tipifarnib..
06:01EDGARCurrent Report Filing (8-k)
11:00GLOBEKura Oncology Reports Clinical and Regulatory Updates for..
06:30GLOBEKura Oncology to Participate in Piper Jaffray Healthcare..
06:30GLOBEKura Oncology to Present at Stifel Healthcare Conference
08:06GLOBEKura Oncology Announces Upcoming Presentation at ASH Annual..
16:24EDGARStatement of Changes in Beneficial Ownership (4)
16:24EDGARInitial Statement of Beneficial Ownership (3)
15:18EDGARQuarterly Report (10-q)
15:11EDGARCurrent Report Filing (8-k)
15:05GLOBEKura Oncology Reports Third Quarter 2019 Financial Results..
06:30GLOBEKura Oncology Appoints James Basta as Chief Legal Officer
08:02EDGARCurrent Report Filing (8-k)
06:30GLOBEKura Oncology to Report Third Quarter 2019 Financial Results
10:50GLOBEKura Oncology Reports Durable Anti-Tumor Activity in Phase 2..
15:05GLOBEKura Oncology Data Selected for Oral Presentation at..
15:30GLOBEKura Oncology Announces Upcoming Presentation at..
15:07EDGARStatement of Changes in Beneficial Ownership (4)
15:07EDGARInitial Statement of Beneficial Ownership (3)
07:01EDGARCurrent Report Filing (8-k)
06:30GLOBEKura Oncology Expands Board of Directors with Appointment of..
06:30GLOBEKura Oncology Doses First Patient in Phase 1 Clinical Trial..
07:03EDGARCurrent Report Filing (8-k)
06:30GLOBEKura Oncology Announces Positive Phase 2 Trial of Tipifarnib..
06:30GLOBEKura Oncology to Participate in Two Upcoming Investor..
05:00EDGARNotice of Effectiveness (effect)
16:30EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
15:08EDGARSecurities Registration Statement (simplified Form) (s-3/a)
17:18EDGARStatement of Changes in Beneficial Ownership (4)
17:17EDGARInitial Statement of Beneficial Ownership (3)
15:15EDGARCurrent Report Filing (8-k)
15:05GLOBEKura Oncology Announces Appointment of Kathleen Ford as..
06:30GLOBEKura Oncology to Present at Wedbush PacGrow Healthcare..
15:38EDGARSecurities Registration Statement (simplified Form) (s-3)
15:19EDGARQuarterly Report (10-q)
15:08EDGARCurrent Report Filing (8-k)
15:05GLOBEKura Oncology Reports Second Quarter 2019 Financial Results..
06:30GLOBEKura Oncology to Report Second Quarter 2019 Financial..
06:30GLOBEKura Oncology’s Menin-MLL Inhibitor KO-539 Receives Orphan..
15:05EDGARStatement of Changes in Beneficial Ownership (4)
06:30GLOBEKura Oncology Expands Protection for Tipifarnib with New..
13:59EDGARAmended Statement of Ownership (sc 13g/a)
See more news about this stock »
Your Recent History
NASDAQ
KURA
Kura Oncol..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200118 01:20:54